Research Article
KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
Figure 2
Correlation between the expression of KNSTRN and TNM tumor stages. (a–e) Determination of pan-cancer KNSTRN expression in four different TNM stages from TCGA database. The left panel represents stage I-IV and the right panel merges stage I with stage II, and merges stage III with stage IV. ; ns: not significant.
(a) |
(b) |
(c) |
(d) |
(e) |